1. Frieden TR, Jaffe HW, Cono J, Richards CL, Iademarco MF. Clinical guidance for smallpox vaccine use in a postevent vaccination program. MMWR. 2015;64(RR2):1-32.
2. Centers for Disease Control and Prevention. Smallpox: Vaccines. Available at https://www.cdc.gov/smallpox/clinicians/vaccines.html. Last accessed November 19, 2021.
3. Brennan JG, Henderson DA. Diagnosis and management of smallpox. N Engl J Med. 2002;346(17):1300-1308.
4. U.S. Food and Drug Administration. ACAM2000 (Smallpox Vaccine): Questions and Answers. Available at https://www.fda.gov/vaccines-blood-biologics/vaccines/acam2000-smallpox-vaccine-questions-and-answers. Last accessed November 19, 2021.
5. Centers for Disease Control and Prevention. Notice to readers: newly licensed smallpox vaccine to replace old smallpox vaccine. MMWR. 2008;57(08):207-208.
6. U.S. Department of Health and Human Services. Strategic National Stockpile (SNS). Available at https://www.phe.gov/about/sns/Pages/default.aspx. Last accessed November 19, 2021.
7. Wharton M, Strikas RA, Harpaz R, et al. Recommendations for using smallpox vaccine in a pre-event vaccination program: supplemental recommendations of the Advisory Committee on Immunization Practices (ACIP) and the Healthcare Infection Control Practices Advisory Committee (HICPAC). MMWR. 2003;52(RR07):1-16.
8. Centers for Disease Control and Prevention. Smallpox: Who Should Get Vaccination. Available at https://www.cdc.gov/smallpox/vaccine-basics/who-gets-vaccination.html. Last accessed November 19, 2021.
9. Military Health System. Smallpox Vaccine Questions and Answers. Available athttps://www.health.mil/Military-Health-Topics/Health-Readiness/Immunization-Healthcare/Vaccine-Preventable-Diseases/Smallpox-ACAM2000/Smallpox-FAQs. Last accessed November 19, 2021.
10. Grabenstein JD, Winkenwerder W Jr. U.S. military smallpox vaccination program experience. JAMA. 2003;289(24):3278-3282.
11. Mount Sinai Hospital Department of Microbiology. Frequently Asked Questions. Available at https://eportal.mountsinai.ca/Microbiology//faq/transmission.shtml. Last accessed November 19, 2021.
12. Lane JM, Goldstein J. Evaluation of 21st-century risks of smallpox vaccination and policy options. Ann Intern Med. 2003;138(6):488-493.
13. Belongia EA, Naleway AL. Smallpox vaccine: the good, the bad, and the ugly. Clin Med Res. 2003;1(2):87-92.
14. Artenstein AW, Grabenstein JD. Smallpox vaccines for biodefense: need and feasibility. Expert Rev Vaccines. 2008;7(8):1225-1237.
15. Barquet N, Domingo P. Smallpox: the triumph over the most terrible of the ministers of death. Ann Intern Med. 1997;127(8):635-642.
16. Veenema TG, Toke J. Early detection and surveillance for biopreparedness and emerging infectious diseases. Online J Issues Nurs. 2006;11(1).
17. Riedel S. Edward Jenner and the history of smallpox and vaccination. Proc (Bayl Univ Med Cent). 2005;18(1):21-25.
18. Hays JN. Epidemics and Pandemics: Their Impacts on Human History. Santa Barbara, CA: ABC-CLIO; 2005.
19. Lucey DR, Breman JG, Henderson DA. Smallpox and bioterrorism. In: Lutwick LI, Lutwick SM (eds). Beyond Anthrax: The Weaponization of Infectious Diseases. Towata, NJ: Humana Press; 2009: 17-54.
20. Centers for Disease Control and Prevention. CDC Media Statement on Newly Discovered Smallpox Specimens. Available at https://www.cdc.gov/media/releases/2014/s0708-nih.html. Last accessed November 19, 2021.
21. Centers for Disease Control and Prevention. Vaccinia (smallpox) vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2001. MMWR. 2001;50(RR10):1-25.
22. Hussain AN, Hussain F, Alam M, Cleri DJ. Smallpox. Available at https://emedicine.medscape.com/article/237229-overview. Last accessed November 19, 2021.
23. Eichner M, Dietz K. Transmission potential of smallpox: estimates based on detailed data from an outbreak. Am J Epidemiol. 2003;158(2):110-117.
24. Henderson DA, Inglesby TV, Bartlett JG, et al. Smallpox as a biological weapon: medical and public health management. JAMA. 1999;281(22):2127-2137.
25. Centers for Disease Control and Prevention. Smallpox: Transmission. Available at https://www.cdc.gov/smallpox/transmission/index.html. Last accessed November 19, 2021.
26. Dembek ZF Col, Alves DA LTC, Cieslak TJ COL, et al. USAMRIID'S Medical Management of Biological Casualties Handbook. 8th ed. Frederick, MD: U.S. Army Medical Research Institute of Infectious Diseases; 2014.
27. Centers for Disease Control and Prevention. Smallpox: Clinical Disease. Available at https://www.cdc.gov/smallpox/clinicians/clinical-disease.html. Last accessed November 19, 2021.
28. Alibek K, Handelman S. Biohazard: The Chilling True Story of the Largest Covert Biological Weapons Program in the World. New York, NY: Random House; 1999.
29. Centers for Disease Control and Prevention. Evaluating Patients for Smallpox. Available at https://www.cdc.gov/smallpox/pdfs/smallpox-diagnostic-algorithm-poster-2-pages.pdf. Last accessed November 19, 2021.
30. Centers for Disease Control and Prevention. Smallpox: Diagnosis and Evaluation. Acute, Generalized Vesicular or Pustular Rash Illness Testing Protocol in the United States. Available at https://www.cdc.gov/smallpox/clinicians/diagnosis-evaluation.html. Last accessed November 19, 2021.
31. Fenner F, Henderson DA, Arita I, Ježek Z, Ladnyi ID. Smallpox and Its Eradication. Geneva: World Health Organization; 1989.
32. Jezek Z, Hardjotanojo W, Rangaraj AG. Facial scarring after varicella: a comparison with variola major and variola minor. Am J Epidemiol. 1981;114(6):798-803.
33. Semba RD. The ocular complications of smallpox and smallpox immunization. Arch Ophthalmol. 2003;121(5):715-719.
34. Jacobs BL, Langland JO, Kibler KV, et al. Vaccinia virus vaccines: past, present and future. Antiviral Res. 2009;84(1):1-13.
35. Hamborsky J, Kroger A, Wolfe C (eds). Epidemiology and Prevention of Vaccine-Preventable Diseases (The Pink Book). 13th ed. Washington, DC: Public Health Foundation; 2015.
36. U.S. Food and Drug Administration. FDA Approves the First Drug with an Indication for Treatment of Smallpox. Available at https://www.fda.gov/news-events/press-announcements/fda-approves-first-drug-indication-treatment-smallpox. Last accessed November 19, 2021.
37. Public Health Emergency. HHS Sponsors New Formulation of World's First Approved Smallpox Drug. Available at https://www.phe.gov/Preparedness/news/Pages/tpoxx-25sept2018.aspx. Last accessed November 19, 2021.
41. Shchelkunov SN, Marennikova SS, Moyer RW. Orthopoxviruses Pathogenic for Humans. 1st ed. New York, NY: Springer Publishing Company; 2005.
42. Lau CY, Wahl B, Foo WK. Ring vaccination versus mass vaccination in event of a smallpox attack. Hawaii Med J. 2005;64(2):34-36, 53.
43. Centers for Disease Control and Prevention. Smallpox: Bioterrorism: Preparedness. Available at https://www.cdc.gov/smallpox/bioterrorism/public/preparedness.html. Last accessed November 19, 2021.
44. Bhattacharya S, Brimnes N. Simultaneously global and local: reassessing smallpox vaccination and its spread, 1789–1900. Bull Hist Med. 2009;83(1):1-16.
45. Petersen BW, Damon IK, Pertowski CA, et al. Clinical guidance for smallpox vaccine use in a postevent vaccination program. MMWR Recomm Rep. 2015;64(RR-02):1-26.
46. Taub DD, Ershler WB, Janowski M, et al. Immunity from smallpox vaccine persists for decades: a longitudinal study. Am J Med. 2008;121(12):1058-1064.
47. Gillis J. Safer Smallpox Vaccines in Works. Available at http://www.washingtonpost.com/wp-dyn/content/article/2005/11/13/AR2005111301006.html?noredirect=on. Last accessed November 19, 2021.
48. Michael LJ. Development of Newer Smallpox Vaccines. Available at http://austinpublishinggroup.com/infectious-diseases/fulltext/ajid-v3-id1025.php. Last accessed November 19, 2021.
49. Zitzmann-Roth EM, von Sonnenburg F, de la Motte S, et al. Cardiac safety of Modified Vaccinia Ankara for vaccination against smallpox in a young, healthy study population. PLoS One. 2015;10(4):e0122653.
51. U.S. Food and Drug Administration. FDA Approves First Live, Non-Replicating Vaccine to Prevent Smallpox and Monkeypox. Available at https://www.fda.gov/news-events/press-announcements/fda-approves-first-live-non-replicating-vaccine-prevent-smallpox-and-monkeypox. Last accessed November 19, 2021.
52. Frey SE, Newman FK, Kennedy JS, et al. Clinical and immunologic responses to multiple doses of IMVAMUNE (Modified Vaccinia Ankara) followed by Dryvax challenge. Vaccine. 2007;25:8562-8573.
53. Vollmar J, Arndtz N, Eckl KM, et al. Safety and immunogenicity of IMVAMUNE, a promising candidate as a third generation smallpox vaccine. Vaccine. 2006;24:2065-2070.
54. von Krempelhuber A, Vollmar J, Pokorny R, et al. A randomized, double-blind, dose-finding Phase II study to evaluate immunogenicity and safety of the third-generation smallpox vaccine candidate IMVAMUNE. Vaccine. 2010;28:1209-1216.
55. Frey SE, Winokur PL, Salata RA, et al. Safety and immunogenicity of IMVAMUNE smallpox vaccine using different strategies for a post event scenario. Vaccine. 2013;31:3025-3033.
56. Greenberg RN, Overton ET, Haas DW, et al. Safety, immunogenicity, and surrogate markers of clinical efficacy for modified vaccinia Ankara as a smallpox vaccine in HIV-infected subjects. J Infect Dis. 2013;207:749-758.
57. Walsh SR, Wilck MB, Dominguez DJ, et al. Safety and immunogenicity of modified vaccinia Ankara in hematopoietic stem cell transplant recipients: a randomized, controlled trial. J Infect Dis. 2013;207:1888-1897.
58. Center for Infectious Disease Research and Policy. Smallpox: Vaccination. Available at http://www.cidrap.umn.edu/infectious-disease-topics/smallpox#overview&1-7. Last accessed November 19, 2021.
59. Bavarian Nordic. MVA-BN Freeze-Dried. Available at https://www.bavarian-nordic.com/what-we-do/pipeline/smallpox.aspx. Last accessed November 19, 2021.
60. World Health Organization. WHO Advisory Committee on Variola Virus Research: Report of the Twenty-First Meeting. Available at https://apps.who.int/iris/bitstream/handle/10665/336343/9789240012998-eng.pdf. Last accessed November 19, 2021.
61. Centers for Disease Control and Prevention. Smallpox: Signs and Symptoms. Available at https://www.cdc.gov/smallpox/symptoms/index.html. Last accessed November 19, 2021.
62. Centers for Disease Control and Prevention. Influenza (Flu): Frequently Asked Flu Questions 2021–2022 Influenza Season. Available at https://www.cdc.gov/flu/season/faq-flu-season-2021-2022.htm. Last accessed November 19, 2021.
63. National Institute of Allergy and Infectious Diseases. Vaccine Types. Available at https://www.niaid.nih.gov/research/vaccine-types. Last accessed November 19, 2021.
64. Taber's Online. Cell-Mediated Immunity. Available at http://www.tabers.com/tabersonline. Last accessed November 19, 2021.
65. Centers for Disease Control and Prevention. Smallpox: Contraindications to Vaccination. Available at https://www.cdc.gov/smallpox/clinicians/vaccination-contraindications1.html. Last accessed November 19, 2021.
66. U.S. Food and Drug Administration. ACAM2000: Package Insert. Available at https://www.fda.gov/vaccines-blood-biologics/vaccines/acam2000. Last accessed November 19, 2021.
67. U.S. Food and Drug Administration. Cylex Inc. Immune Cell Function Assay. Available at https://www.accessdata.fda.gov/cdrh_docs/pdf10/K101911.pdf. Last accessed November 19, 2021.
68. Centers for Disease Control and Prevention. Vaccination of Persons with Primary and Secondary Immune Deficiencies. Available at https://www.cdc.gov/vaccines/pubs/pinkbook/downloads/appendices/A/immuno-table.pdf. Last accessed November 19, 2021.
69. U.S. Department of Health and Human Services. Centers for Disease Control and Prevention. Vaccine Storage and Handling Toolkit. Available at https://www.cdc.gov/vaccines/hcp/admin/storage/toolkit/storage-handling-toolkit.pdf. Last accessed November 19, 2021.
70. Lexi-Comp Online. Available at http://online.lexi.com. Last accessed November 19, 2021.
71. ACAM2000 Smallpox (Vaccinia) Vaccine, Live. Deployment Guidance: DoD. Available at https://docplayer.net/5420151-Acam2000-smallpox-vaccinia-vaccine-live-deployment-guidance-dod.html. Last accessed November 19, 2021.
72. Centers for Disease Control and Prevention. Smallpox: Packaging and Transporting Infectious Substances. Available at https://www.cdc.gov/smallpox/lab-personnel/specimen-collection/pack-transport.html. Last accessed November 19, 2021.
73. Centers for Disease Control and Prevention. Smallpox: Bioterrorism Response Planning. Available at https://www.cdc.gov/smallpox/bioterrorism-response-planning/index.html. Last accessed November 19, 2021.
74. Military Health System. Smallpox: DoD Smallpox Vaccination Program Resource Center. Available at https://www.health.mil/Military-Health-Topics/Health-Readiness/Immunization-Healthcare/Vaccine-Preventable-Diseases/Smallpox-ACAM2000. Last accessed November 19, 2021.
75. Centers for Disease Control and Prevention. Handwashing: Clean Hands Save Lives. Available at https://www.cdc.gov/handwashing. Last accessed November 19, 2021.
76. Centers for Disease Control and Prevention. When and How to Wash Your Hands. Available at https://www.cdc.gov/handwashing/when-how-handwashing.html. Last accessed November 19, 2021.
77. Centers for Disease Control and Prevention. Guideline for hand hygiene in health-care settings: recommendations of the Healthcare Infection Control Practices Advisory Committee and the HICPAC/SHEA/APIC/IDSA Hand Hygiene Task Force. MMWR. 2002;51(RR16):1-45.
78. Centers for Disease Control and Prevention. Smallpox: Expected Vaccine Reactions. Available at https://www.cdc.gov/smallpox/clinicians/vaccination-expected-reaction3.html. Last accessed November 19, 2021.
79. Centers for Disease Control and Prevention. Vaccine "Take" Evaluation. Available at https://www.cdc.gov/smallpox/clinicians/vaccination-take-evaluation4.html. Last accessed November 19, 2021.
80. Centers for Disease Control and Prevention. Smallpox: Vaccine Adverse Events. Available at https://www.cdc.gov/smallpox/clinicians/vaccine-adverse-events5.html. Last accessed November 19, 2021.
81. Fulginiti V, Henderson DA, Papier A. Smallpox Vaccination, Vaccination Method and Reactions. Version 2. Rochester, NY: Logical Images, Inc.; 2003.
82. Cono J, Casey CG, Bell DM. Smallpox vaccination and adverse reactions: guidance for clinicians. MMWR. 2003;52(RR4):1-28.
83. Centers for Disease Control and Prevention. Medical Management of Adverse Reactions. Available at https://www.cdc.gov/smallpox/clinicians/vaccine-medical-management6.html. Last accessed November 19, 2021.
84. Centers for Disease Control and Prevention. Smallpox: Side Effects of Smallpox Vaccination. Available at https://www.cdc.gov/smallpox/vaccine-basics/vaccination-effects.html. Last accessed November 19, 2021.
85. Vaccine Adverse Event Reporting System. Available at https://vaers.hhs.gov/index.html. Last accessed November 19, 2021.
86. National Eczema Association. Eczema Facts. Available at https://nationaleczema.org/research/eczema-facts. Last accessed November 19, 2021.
87. Centers for Disease Control and Prevention. Vaccinia Immune Globulin Intravenous (Human) (VIGIV). Available at https://www.fda.gov/downloads/BiologicsBloodVaccines/BloodBloodProducts/ApprovedProducts/LicensedProductsBLAs/FractionatedPlasmaProducts/UCM179514.pdf. Last accessed November 19, 2021.
88. Damon IK, Damaso CR, McFadden G. Are we there yet? The smallpox research agenda using variola virus. PLoS Pathog. 2014;10(5):e1004108.
89. Centers for Disease Control and Prevention. Vaccine Administration: Step-by-Step Instructions. Available at https://www.cdc.gov/smallpox/clinicians/vaccination-administration2.html. Last accessed November 19, 2021.
90. McLaughlin LA, Braun KL. Asian and Pacific Islander cultural values: considerations for health care decision making. Health Soc Work. 1998;23(2):116-126.
91. Ivashkov Y, Van Norman GA. Informed consent and the ethical management of the older patient. Anesthesiol Clin. 2009;27(3): 569-580.
93. Carrese JA, Rhodes LA. Western bioethics on the Navajo reservation: benefit or harm? JAMA. 1995;274(10):826-829.
94. Rashad AM. Obtaining informed consent in an Egyptian research study. Nurs Ethics. 2004;11(4):394-399.
95. Yick AG, Berthold SM. Conducting research on violence in Asian American communities: methodological issues. Violence Vict. 2005;20(6):661-677.
96. Centers for Disease Control and Prevention. CDC Interim Guidance for Revaccination of Eligible Persons who Participated in the U.S. Civilian Smallpox Preparedness and Response Program. Available at https://www.cdc.gov/smallpox/pdfs/revaccination-memo.pdf. Last accessed November 19, 2021.
97. Centers for Disease Control and Prevention. About Monkeypox. Available at https://www.cdc.gov/poxvirus/monkeypox/about.html. Last accessed June 2, 2022.
98. Centers for Disease Control and Prevention. U.S. Monkeypox 2022: Situation Summary. Available at https://www.cdc.gov/poxvirus/monkeypox/response/2022/index.html. Last accessed July 18, 2022.
99. World Health Organization. Multi-Country Monkeypox Outbreak in Non-Endemic Countries. Available at https://www.who.int/emergencies/disease-outbreak-news/item/2022-DON385. Last accessed June 2, 2022.
100. Centers for Disease Control and Prevention. Monkeypox: Clinical Recognition. Available at https://www.cdc.gov/poxvirus/monkeypox/clinicians/clinical-recognition.html. Last accessed June 2, 2022.
Mention of commercial products does not indicate endorsement.